Showing results (111-120 of 424) with videos related to

Sort By:
Pageof 43
BMC Gastroenterology|April 24, 2010
Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)Thierry Poynard, Pascal Lebray, Patrick Ingiliz, et al.
Journal of Hepatology|September 26, 2008
Hepatitis C infection and risk of diabetes: a systematic review and meta-analysisDonna L White, Vlad Ratziu, Hashem B El-Serag
Nature Reviews. Gastroenterology & Hepatology|June 9, 2016
Critical comparison of elastography methods to assess chronic liver diseaseMireen Friedrich-Rust, Thierry Poynard, Laurent Castera
Journal of Hepatology|May 29, 2013
Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis CThierry Poynard, Joseph Moussalli, Mona Munteanu, et al.
Clinics in Liver Disease|November 27, 2013
The interactions of nonalcoholic fatty liver disease and cardiovascular diseasesHugo Perazzo, Thierry Poynard, Jean-François Dufour
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 15, 2013
Hepatic molecular effects of rosiglitazone in human non-alcoholic steatohepatitis suggest long-term pro-inflammatory damageMaud Lemoine, Lawrence Serfaty, Pascale Cervera, et al.
Transplantation|October 10, 2018
Recommendations for Management and Treatment of Nonalcoholic SteatohepatitisVlad Ratziu, Marwan Ghabril, Manuel Romero-Gomez, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|June 17, 2016
Real-life Perception and Practice Patterns of NAFLD/NASH in Romania: Results of a Survey Completed by 102 Board-certified GastroenterologistsSperanta Iacob, Carmen Ester, Mihaela Lita, et al.
Hepatology (Baltimore, Md.)|August 21, 2018
Relationship Among Fatty Liver, Specific and Multiple-Site Atherosclerosis, and 10-Year Framingham ScoreRaluca Pais, Alban Redheuil, Philippe Cluzel, et al.
Pageof 43